Valuation: GENFIT

Market Cap 733M 844M 683M 627M 1.18B 80.53B 1.2B 8.05B 3.16B 40.09B 3.17B 3.1B 134B P/E 2026 *
37.8x
P/E 2027 * 97.3x
Enterprise Value 682M 785M 635M 583M 1.1B 74.92B 1.12B 7.49B 2.94B 37.3B 2.95B 2.88B 125B EV / Sales 2026 *
6.81x
EV / Sales 2027 * 5.38x
Free-Float
86.88%
Yield 2026 *
-
Yield 2027 * -
1 day+4.71%
1 week+9.08%
1 month+42.33%
3 months+81.44%
6 months+161.79%
Current year+178.44%
1 week 12.94
Extreme 12.94
15.48
1 month 11.1
Extreme 11.1
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
+4.71%+9.08%+335.27%+335.01% 844M
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+411.96%+495.33% 39.87B
-1.16%+12.96%+28.81%+7.25% 38.68B
-1.88%-3.03%+5.69%+53.00% 35.13B
-1.74%+5.12%+14.44%+41.77% 29.79B
-0.21%-4.04%+36.40%+125.75% 16.11B
-2.85%-3.92% - - 16.08B
-0.64%+2.65%+3.40%+13.11% 13.61B
-1.19%-1.32%-1.73%-34.37% 12.62B
Average -0.88%+1.85%+92.50%+116.46% 25.13B
Weighted average by Cap. -1.58%+2.06%+80.70%+109.43%

Financials

2026 *2027 *
Net sales 100M 115M 93.26M 85.63M 162M 11B 164M 1.1B 431M 5.48B 433M 423M 18.37B 124M 143M 115M 106M 200M 13.62B 203M 1.36B 534M 6.78B 536M 524M 22.74B
Net income 22.88M 26.32M 21.29M 19.55M 36.92M 2.51B 37.49M 251M 98.51M 1.25B 98.84M 96.67M 4.19B 6.8M 7.82M 6.33M 5.81M 10.97M 747M 11.14M 74.61M 29.28M 372M 29.38M 28.73M 1.25B
Net Debt -51.12M -58.8M -47.58M -43.68M -82.49M -5.61B -83.77M -561M -220M -2.79B -221M -216M -9.37B -66.17M -76.12M -61.59M -56.55M -107M -7.27B -108M -726M -285M -3.62B -286M -280M -12.13B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
31/07/26 EUR 14.66 +4.71% 1,052,589
30/07/26 EUR 14.00 +3.09% 472,097
29/07/26 EUR 13.58 +2.88% 221,321
28/07/26 EUR 13.20 -3.23% 309,495
27/07/26 EUR 13.64 +1.49% 267,519
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.66EUR
Average target price
15.90EUR
Spread / Average Target
+8.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock